{"id":797372,"title":"Archived 35: Summary of NACI statement of March 17, 2022:  Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-03-11","captureTimestamp":"2026-03-11T20:38:34.912000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-moderna-spikevax-covid-19-vaccine-children-6-11-years-age/summary-march-17-2022.html","snippet":"Archived 35: Summary of NACI statement of March 17, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age Notice to reader This is an archived version. Please refer to current COVID-19 vaccine pages: NACI statements and…","rawSnapshotUrl":"/api/snapshots/raw/797372","browseUrl":"https://replay.healtharchive.ca/job-7/20260311203834/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-moderna-spikevax-covid-19-vaccine-children-6-11-years-age/summary-march-17-2022.html#ha_snapshot=797372","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}